Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?

Author： Giovannetti Elisa   Toffalorio Francesca   De Pas Tommaso   Peters Godefridus J  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.9, 2012-07, pp. : 1073-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Advances in chemotherapy in advanced non-small-cell lung cancer

By Maione Paolo   Rossi Antonio   Sacco Paola Claudia   Bareschino Maria Anna   Schettino Clorinda   Gridelli Cesare  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2997-3007

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 893-898

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E.   Easthope Stephanie E.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li   de Boer Richard H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-small-cell lung cancer

By Felip Enriqueta   Santarpia Mariacarmela   Rosell Rafael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 449-460

Informa Healthcare

Access to resources Recommend Favorite